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Human exposure to the toxic metal cadmium 
(Cd) occurs mainly through food, such as 
cereals, seafood, and offal, and inhalation of 
tobacco smoke (Järup and Åkesson 2009). 
Once absorbed, Cd has a long half-life in 
the body, especially in the kidneys. Chronic 
Cd exposure has been shown to adversely 
affect kidney and bone and to increase the 
risk of cancer (Straif et al. 2009) and overall 
mortality (Järup and Åkesson 2009). Cd also 
functions as an endocrine disruptor (Ali et al. 
2010; Johnson et al. 2003) and may thus 
affect reproduction and child development 
(Henson and Chedrese 2004). In general, 
women are more susceptible to Cd toxicity, 
mainly because of increased intestinal uptake 
of Cd given low iron stores (Åkesson et al. 
2002; Berglund et al. 1994; Nishijo et al. 
2004a; Vahter et al. 2007), which are more 
prevalent in women than in men.
There is, however, little information on 
the effects of Cd exposure in early life. Cd 
has been shown to be both embryotoxic and 
teratogenic in a variety of animal species 
(Thompson and Bannigan 2008), but this 
has not yet been confirmed in humans. Cd 
accumulates in human placenta (Kippler et al. 
2010a; Osman et al. 2000), but the placenta is 
not a complete barrier, and Cd concentrations 
in cord blood increase with maternal exposure 
(Kippler et al. 2010a). There is increasing evi-
dence of associations between maternal Cd 
exposure and adverse pregnancy outcomes, 
such as reduced size at birth (Galicia-Garcia 
et al. 1997; Llanos and Ronco 2009; Nishijo 
et al. 2004b; Salpietro et al. 2002; Shirai et al. 
2010; Zhang et al. 2004) and pre  term deliv-
ery (Nishijo et al. 2002). However, studies 
that have reported associations included very 
few women (44–78 women), and associa-
tions with the same outcomes varied markedly 
among the studies. Residual confounding can-
not be excluded because very few covariates 
were considered. In contrast, two larger stud-
ies (106–262 women) found no association 
between maternal Cd exposure and size at 
birth (Odland et al. 1999; Osman et al. 2000).
In the present study, we took advantage 
of our large, population-based, longitudinal 
mother–child cohort in Bangladesh to assess 
the effects of maternal Cd exposure on size 
at birth. We previously reported that arsenic 
(As) exposure is associated with reduced size 
at birth (Rahman et al. 2009). Additionally, 
pregnant women in this rural area had ele-
vated concentrations of Cd in their placentas, 
and placental Cd was inversely associated with 
zinc (Zn) in cord blood, suggesting a possible 
effect of Cd on the transfer of Zn to the fetus 
(Kippler et al. 2010a). Thus, it is possible that 
Cd has adverse effects on pregnancy outcomes 
as well.
Materials and Methods
Study area and design. The present study was 
nested in a population-based food and micro-
nutrient supplementation trial in pregnancy 
in women in rural Bangladesh [Maternal 
and Infant Nutrition Interventions, Matlab 
(MINIMat)], which enrolled approximately 
4,500 pregnant women from November 2001 
through October 2003, as described previously 
(Tofail et al. 2008). During monthly house-
hold visits, community health research work-
ers offered a pregnancy urine test to women 
who had missed their menstrual period. In the 
case of a positive pregnancy test, the women 
were asked to donate a urine sample for future 
analysis and thereafter were invited to the near-
est health center for further examination. The 
present study included the women who were 
identified as pregnant during one calendar year, 
from 1 February 2002 through 31 January 
2003, who were enrolled in the MINIMat trial 
and had a singleton birth with measurements 
of size at birth. In total, 1,697 women fulfilled 
these criteria (Rahman et al. 2009).
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Ba c k g r o u n d: Cadmium (Cd) is an embryotoxic and teratogenic metal in a variety of animal 
  species, but data from humans are limited.
oBjectives: The aim of the present study was to assess the effects of maternal Cd exposure in preg-
nancy on size at birth.
Me t h o d s : This prospective cohort study was nested in a population-based nutritional supplementa-
tion trial in pregnancy conducted in rural Bangladesh. We selected women recruited from February 
2002 through January 2003 who had a singleton birth with measurements of size at birth and had 
donated a urine sample in early pregnancy for Cd analyses (n = 1,616). Urinary Cd was measured 
with inductively coupled plasma mass spectrometry and adjusted for specific gravity.
re s u l t s: Multiple linear regression analyses adjusted for sex and other potential confounders 
showed that maternal urinary Cd (median, 0.63 μg/L) was significantly negatively associated with 
birth weight [unstandardized regression coefficient B = –31.0; 95% confidence interval (CI): –59, 
–2.8] and head circumference (B = –0.15; 95% CI: –0.27, –0.026). However, associations appeared 
to be limited to girls, with little evidence of effects in boys. A 1-μg/L increase in Cd in maternal urine 
was associated with a 0.26-cm (95% CI: –0.43, –0.088 cm) and 0.24-cm (95% CI: –0.44, –0.030 
cm) decrease in girls’ head and chest circumferences, respectively, and a 45-g (95% CI: –82.5, 7.3 g) 
decrease in birth weight. Quantile regression analyses indicated that associations with maternal Cd 
were similar for girls of smaller (25th percentile) and larger (50th and 75th percentiles) sizes at birth.
co n c l u s i o n: We found evidence of a sex difference in the association between maternal Cd expo-
sure and birth size, which was apparent only in girls. Results add support for the need to reduce Cd 
pollution to improve public health.
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International Centre for Diarrhoeal Disease 
Research, Bangladesh (ICDDR,B), as well as 
the regional ethics committee at Karolinska 
Institutet, Sweden. Oral and written consents 
were obtained from the women.
Exposure assessment. Of the 1,697 
women, 1,616 donated a urine sample, on 
average at gestational week 8, and this urine 
sample was used for assessment of Cd expo-
sure. Urinary Cd is a well-documented 
biomarker of chronic exposure (Järup and 
Åkesson 2009). These 1,616 women did not 
significantly differ in age, body mass index 
(BMI), socioeconomic status (SES), or parity, 
or with regard to characteristics of their new-
borns (birth weight, length, head and chest 
circumference) from those who did not pro-
vide a urine sample (n = 81). However, those 
who donated a sample had slightly longer ges-
tation (median, 39.4 weeks) than those who 
did not (median, 39.0 weeks; p = 0.011).
Cd in urine was measured with inductively 
coupled plasma mass spectrometry (ICPMS; 
model 7500ce; Agilent Technologies, 
Waldbronn, Germany) at Karolinska Institutet 
(Stockholm, Sweden). Samples were stored 
at –70°C in acid-washed plastic vials. The 
ICPMS was operated in helium mode and 
111Cd was monitored. The sample preparation 
and analytical methods have been described 
elsewhere (Kippler et al. 2007, 2009). No sam-
ples were below the limit of detection (LOD; 
< 0.02 μg/L). Quality control was assessed by 
analyses of two commercial control materials 
(SeronormTM Trace Elements Urine Blank, 
ref. 201305, lot OK4636, and SeronormTM 
Trace Elements Urine, ref. 201205, lot 
NO2525; SERO AS, Billingstad, Norway). 
The obtained mean (± SD) urinary Cd con-
centrations in the two control materials were 
0.26 ± 0.05 μg/L (recommended value 0.31 
± 0.05) and 4.8 ± 0.14 μg/L (5.06 ± 0.22), 
respectively. We have previously measured 
the sum of inorganic As and its methylated 
metabolites, referred to as urinary As, in these 
women because many are highly exposed to As 
via drinking water (Vahter et al. 2006). These 
measurements were performed with hydride 
generation atomic absorption spectroscopy 
(Vahter et al. 2006). To compensate for varia-
tion in urine dilution, the final Cd and As 
concentrations were adjusted to the mean spe-
cific gravity (1.012 g/mL) of the urine samples 
(Nermell et al. 2008).
Outcomes and covariates. Birth weight 
was measured with electronic or beam scales 
with precision of 10 g (UNICEF Uniscale; 
SECA Gmbh & Co., Hamburg, Germany), 
length with a locally produced wooden length 
board (accurate to 1 mm), and head and chest 
circumference with a flexible non  stretchable 
measuring tape (accurate to 1 mm) (Rahman 
et al. 2009). Approximately 40% of the 
women delivered at the health clinics and had 
birth anthropometry measured in connection 
with the delivery. A birth notification system 
was established for women who delivered at 
home, and birth anthropometry was most 
often measured within 24 hr. If more than 
72 hr had passed since delivery, the weight 
was adjusted as described in detail elsewhere 
(Arifeen et al. 2000). Gestational age was cal-
culated by subtracting the date for the last 
menstrual period from the date of birth. The 
date of last menstrual period was obtained by 
interviewing the women immediately after 
identification of pregnancy. For women who 
had forgotten this date (n = 26), we used the 
last menstrual period estimated by ultrasound 
measurements (Rahman et al. 2009).
Covariate information was obtained during 
household visits by the health research work-
ers and at routine visits at the health facilities, 
as well as from the Health and Demographic 
Surveillance System database maintained by 
ICDDR,B (Dhaka, Bangladesh). Maternal 
height and weight were recorded at the health 
facilities, approximately in gestational week 8. 
Education was defined as years of formal 
schooling and categorized as no education, 
< 5 years, ≥ 5 to < 10 years, and ≥ 10 years. SES 
was classified according to a wealth index based 
mainly on household assets, as described previ-
ously (Gwatkin et al. 2000). Maternal tobacco 
smoking and betel/tobacco chewing during 
pregnancy were defined as never or ever. The 
season of birth was categorized as premonsoon 
(January–May), monsoon (June–September), 
or postmonsoon (October–December).
Statistical analyses. The statistical analyses 
were performed with Statistica for Windows 
(version 9.1; StatSoft, Inc., Tulsa, OK, USA) 
and STATA (version 11; StataCorp., College 
Station, TX, USA). All tests were two sided, 
and a p < 0.05 was considered statistically 
significant. Bivariate analyses between expo-
sures, sizes at birth, and covariates were evalu-
ated by Spearman’s correlation coefficient or 
analysis of variance depending on the type of 
data analyzed. The p-value for the difference 
between two independent groups was deter-
mined with the Mann–Whitney U-test.
We further assessed associations between 
maternal urinary Cd (non  transformed) and 
size at birth (birth weight, birth length, head 
and chest circumference) using multivariable-
adjusted linear regression analyses. The resid-
ual analyses indicated no major deviation 
from the assumptions of linear regression. 
We adjusted for variables significantly associ-
ated with either size at birth or urinary Cd 
(p < 0.05) in the bivariate analyses or that 
had previously been associated with size at 
birth. Maternal age and parity, and maternal 
education and SES were highly correlated 
(rs > 0.50). Therefore, we adjusted for mater-
nal age and SES only, because they were more 
strongly associated with outcomes than were 
parity and maternal education. We evaluated 
colinearity by tolerance and variance inflation 
factor in the linear regression analyses. The 
final multiple linear regression analyses were 
adjusted for maternal age, BMI, SES, hemo-
globin in gestational week 14, urinary As at 
gestational week 8, betel use, season of birth, 
gestational age at birth, and sex. Additionally, 
we stratified by sex and by SES (median 
split) and repeated the above analysis. Also, 
we assessed whether adding the different 
food (early and usual) and/or micronutrient 
supplementations (three different types) into 
the models modified the association between 
Cd and size at birth. We used “seemingly 
  unrelated estimation” in STATA to adjust 
for conducting multiple tests on a set of cor-
related outcomes dealing with size at birth 
and compared these model estimates with 
estimates from the analysis described above.
To assess the effect of maternal urinary 
Cd on the whole distribution of sizes at birth, 
we performed multivariable-adjusted quan-
tile regression analyses using STATA. Linear 
regression models the relationship between a 
set of predictor variables and the mean of the 
response variable. Quantile regression mod-
els the relationship between a set of predictor 
variables and specific percentiles (or quantiles) 
of the response variable. Thus, quantile regres-
sion allows us to estimate associations between 
an exposure and the outcome at different levels 
of the outcome distribution, instead of asso-
ciations with the mean value of the outcome 
only, and thus provides a method to deter-
mine whether a predictor variable, such as Cd, 
may have a different association with birth size 
among children with low birth size compared 
with children with normal birth size (Bottai 
et al. 2010). Additionally, quantile regression 
estimates are robust to outliers in the data set. 
We assessed the 25th percentile (lowest quan-
tile), 50th percentile (median quantile), and 
75th percentile (highest quantile) for the dif-
ferent birth outcomes. Regression models for 
all three quantiles were estimated jointly using 
simultaneous quantile regression in STATA. 
Estimates, confidence intervals (CIs), and 
p-values were based on 200 bootstrap samples. 
The Wald test was used to test for difference 
between the jointly estimated regression coef-
ficients across different quantiles.
Results
The background characteristics and   biomarkers 
of the mothers are presented in Table 1. Of 
the 1,616 mothers, 75% had urinary Cd con-
centration < 1 μg/L. Maternal age ranged from 
14 to 45 years, with an average of 26 years. 
About one-third of the women had a BMI 
< 18.5 kg/m2. None of the women reported 
smoking during pregnancy, but approxi-
mately 38% reported betel chewing. About 
one-third of the women were primiparous, Kippler et al.
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and the multiparous women had on average 
two children (range, one to eight). Table 1 
also shows the descriptive data of the new-
borns; 52% of the newborns were boys, the 
average gestational age was 39 weeks (range, 
29–45 weeks), and around 8% were born pre-
term (< 37 weeks). Birth weight ranged from 
1,059 g to 4,000 g, with an average of 2,672 g. 
After excluding those born pre  term, 38% still 
had a low birth weight (< 2,500 g).
In the bivariate analyses, maternal uri-
nary Cd was not significantly correlated with 
birth weight, length, and head or chest cir-
cumference but was positively correlated with 
maternal age and urinary As concentrations 
and negatively correlated with maternal edu-
cation, SES, and hemoglobin (Table 2). In 
addition, birth outcomes were significantly 
correlated with gestational age at birth and 
with maternal height, weight, BMI, age, par-
ity, SES, and level of education (Table 2).
Urinary Cd did not differ between 
mothers of infants born pre  term (median, 
0.61 μg/L) and those born at term (0.62 μg/L; 
p = 0.77). Multiparous women had signifi-
cantly higher urinary Cd concentrations 
(median, 0.70 μg/L) than did primiparous 
women (median, 0.50 μg/L; p < 0.001), but 
they were also older than the primiparous 
women (median, 29 vs. 21 years of age; 
p < 0.001). Betel chewing was not signifi-
cantly associated with maternal urinary Cd or 
any of the birth outcomes (data not shown).
In girls, urinary Cd was negatively associ-
ated with chest circumference (rs = –0.071, 
p = 0.048), birth weight (rs = –0.055, p = 0.13), 
and birth length (rs = –0.041, p = 0.25). In 
boys, urinary Cd was positively associated 
with birth length (rs = 0.068, p = 0.050) and 
birth weight (rs = 0.027, p = 0.43) and weakly 
associated with reduced chest circumference 
(rs = –0.014, p = 0.68). Head circumference 
was not correlated with maternal urinary Cd 
in girls or boys (rs = –0.0072, p = 0.25; and 
rs = –0.0072, p = 0.83, respectively.)
Multivariable-adjusted linear regression 
analyses, including maternal age, BMI, SES, 
hemoglobin, urinary As, and betel use and 
infant season of birth, gestational age, and sex, 
showed significant associations of maternal uri-
nary Cd with mean birth weight (unstandard-
ized regression coefficient B = –31.0; 95% CI: 
–59, –2.8; p = 0.031; Table 3) and mean head 
circumference (B = –0.15; 95% CI: –0.27, 
–0.026; p = 0.018). Moreover, maternal uri-
nary Cd was close to negatively associated with 
mean chest circumference (B = –0.14; 95% 
CI: –0.30, 0.021; p = 0.088), whereas no asso-
ciation was found with birth length. Sex was 
significant in all models, confirming that, on 
average, girls were smaller than boys (p < 0.001 
for all outcomes). When a multiplicative inter-
action term between urinary Cd and sex was 
included in the multivariable-  adjusted regres-
sion analyses (Table 3), the interaction term 
was not significantly associated with any of 
the birth outcomes (p > 0.05). The stratified 
analyses showed that the inverse associations 
between maternal urinary Cd and mean birth 
outcomes were evident only in girls (Table 3), 
whereas in boys, maternal urinary Cd was not 
associated with any of the birth outcomes. 
Evaluation of effect size with linear regres-
sion analysis showed that a 1-μg/L increase 
in maternal urinary Cd was associated with a 
decrement of 45 g (95% CI: –82.5, –7.3) in 
mean birth weight, 0.26 cm (95% CI: –0.43, 
–0.088) in mean head circumference, and 
0.24 cm (95% CI: –0.44, –0.030) in mean 
chest circumference in girls. Results were con-
sistent with those shown when associations 
were estimated using seemingly unrelated 
post  estimation to account for multiple test-
ing on correlated outcomes (p-values shown 
in Table 3). We further stratified for high and 
low SES (median split) and found that the 
effect estimates of Cd did not change signifi-
cantly in girls or boys (data not shown).
We also performed multivariable-adjusted 
linear regression analyses with gestational age 
at birth as the dependent variable, adjusting 
for all potential confounders. There was no 
significant association with maternal urinary 
Cd in the cohort as a whole, or in girls or boys 
(data not shown). Adding the different food 
and micronutrient supplementations that were 
ingested during pregnancy into the models did 
not modify the associations between Cd and 
size at birth (data not shown), even when the 
analysis was restricted to the girls.
The multivariable-adjusted quantile regres-
sion analysis confirmed that maternal urinary 
Table 1. Characteristics of the mothers and their newborns.
Characteristic n
Mean ± SD (range) 
or percent Median
25th–75th 
percentile
Maternal
Age (years) 1,616 27 ± 6.0 (14–45) 26 22–31
Weight (kg)a 1,612 45 ± 6.6 (25–74) 44 40–49
Height (cm) 1,616 150 ± 5.2 (134–170) 150 146–153
BMI (kg/m2)a 1,612 20 ± 2.6 (13–31) 20 18–21
< 18.5 488 30
≥ 18.5 1,127 70
Parity 1,616 1.4 ± 1.4 (0–8) 1 0–2
Primiparous 529 33
Multiparous 1,087 67
Urinary Cd (μg/L)a 1,616 0.81 ± 0.67 (0.044–7.0) 0.63 0.38–1.0
Urinary As (μg/L)a 1,509 152 ± 175 (1.2–1,235) 80 37–206
Hemoglobin (g/dL)b 1,504 11.6 ± 1.3 (8.0–17.3) 11.6 10.8–12.4
Tobacco smoking (yes/no) 1,562 (0/100)
Betel chewing (yes/no) 1,562 38/62
Newborns
Sex (male/female) 1,616 52/48
Gestational age (weeks) 1,611 39 ± 1.8 (29–45) 39 38–40
< 37 130 8
≥ 37 1,481 92
Weight (g) 1,616 2,672 ± 414 (1,059–4,000) 2,677 2,419–2,930
< 2,500 520 32
≥ 2,500 1,096 68
Length (cm) 1,603 48 ± 2.3 (38–60) 48 47–49
Head circumference (cm) 1,608 32 ± 1.6 (24–40) 33 31–34
Chest circumference (cm) 1,608 31 ± 2.2 (22–53) 31 30–33
aGestational week 8. bGestational week 14.
Table 2. Spearman’s rank correlation coefficients (p-value) of associations between exposures, maternal 
covariates, and child anthropometry measures at birth.
Child measures
Maternal 
urinary Cd (μg/L) Variable Weight (g) Length (cm)
Head 
circumference (cm)
Chest 
circumference (cm)
Urinary Cd –0.011 (0.65) 0.014 (0.57) –0.029 (0.24) –0.040 (0.11) —
Urinary As –0.0067 (0.80) –0.036 (0.16) –0.066 (0.011) –0.067 (0.0090) 0.088 (0.0059)
Hemoglobin –0.0059 (0.82) –0.000079 (0.99) 0.029 (0.26) 0.033 (0.20) –0.059 (0.021)
Age 0.099 (< 0.001) 0.083 (< 0.001) 0.050 (0.045) 0.067 (0.0075) 0.22 (< 0.001)
Paritya 0.13 (< 0.001) 0.069 (0.043) 0.044 (0.10) 0.052 (0.039) 0.18 (< 0.001)
Height 0.24 (< 0.001) 0.27 (< 0.001) 0.16 (< 0.001) 0.19 (< 0.001) –0.046 (0.062)
Weight 0.32 (< 0.001) 0.27 (< 0.001) 0.24 (< 0.001) 0.28 (< 0.001) –0.024 (0.34)
BMI 0.24 (< 0.001) 0.17 (< 0.001) 0.18 (< 0.001) 0.22 (< 0.001) –0.0098 (0.69)
SES 0.13 (< 0.001) 0.17 (< 0.001) 0.13 (< 0.001) 0.15 (< 0.001) –0.19 (< 0.001)
Educationb 0.10 (< 0.001) 0.15 (< 0.001) 0.068 (< 0.001) 0.10 (< 0.001) –0.17 (< 0.001)
Gestational age 0.40 (< 0.001) 0.43 (< 0.001) 0.37 (< 0.001) 0.36 (< 0.001) –0.0062 (0.80)
aParity (primiparous vs. multiparous). bEducation (no education, < 5 years education, ≥ 5 to < 10 years, ≥ 10 years).Maternal cadmium exposure and birth size
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Cd was associated with birth size in girls but 
not in boys (Figure 1). Moreover, the results 
indicate that the associations between maternal 
urinary Cd and size at birth were very similar 
across the different percentiles of each outcome.
Discussion
The present study, which to our knowledge 
is the largest to estimate effects of Cd on fetal 
development, shows an unexpected difference 
in the association between maternal Cd expo-
sure during pregnancy and infant size at birth 
by sex, with inverse associations in girls but 
little evidence of an effect in boys. The stron-
gest associations were found for head circum-
ference and birth weight. A 1-μg/L increase 
in Cd in maternal urine during pregnancy 
was associated with a decrease in head cir-
cumference of 0.26 cm and in birth weight of 
45 g in girls. The magnitude of the estimated 
effects is not necessarily of clinical importance 
for individual children but may have consid-
erable public health relevance given the high 
prevalence of elevated exposure to Cd, mainly 
through the diet.
The main strengths of this study include 
the prospective study design and the large 
sample size with a wide range of Cd exposure. 
Also, we had extensive data on potential con-
founders, including maternal age, nutrition, 
season of birth, and SES. We also adjusted 
for As exposure and betel chewing, which 
have previously been associated with size at 
birth (Rahman et al. 2009; Senn et al. 2009). 
However, we cannot rule out the possibility 
that our findings may still be biased by unmea-
sured confounders or by residual confounding. 
We assessed individual maternal Cd exposure 
by concentrations in urine, a well-recognized 
biomarker of chronic Cd exposure (Järup and 
Åkesson 2009). Urinary Cd concentrations 
were adjusted for specific gravity, because 
  creatinine-adjustment is highly dependent on 
body composition and type of diet (Nermell 
et al. 2008), which may also be associated with 
birth weight. The analytical measurements 
were performed with an ICPMS method 
with high sensitivity and efficient removal of 
potential interferences (e.g., molybdenum). 
We selected all the women who were identi-
fied as pregnant during one calendar year, to 
cover potential temporal variation, especially in 
size at birth. Furthermore, none of the women 
smoked, which otherwise would have been a 
major confounder, because smoking is associ-
ated with several adverse outcomes of preg-
nancy, including low birth weight (DiFranza 
and Lew 1995), as well as increased Cd expo-
sure (Olsson et al. 2002).
We tested the robustness of our findings 
using both conventional multivariate linear 
regression models and quantile regression 
models. The quantile regression estimates for 
the median generally agreed with the linear 
regression estimates in terms of direction and 
magnitude, indicating that the linear regres-
sion estimates were not unduly influenced 
by outlying values. We did not find any evi-
dence that Cd differentially affected children 
of smaller size.
A limitation of the study is that we did 
not measure Cd in cord blood, which might 
have provided more precise information of the 
prenatal Cd exposure. Two previous studies, 
although limited in size (49 and 45 women), 
found inverse associations between cord blood 
Cd concentrations and birth weight (Galicia-
Garcia et al. 1997; Salpietro et al. 2002). 
Another study reported a significant inverse 
association with head circumference, but not 
with birth weight (Lin et al. 2010). However, 
the effect on fetal growth may at least partly be 
related to the accumulation of Cd in placenta 
because it is associated with impaired transport 
of nutrients to the fetus. Indeed, placental Cd 
concentrations have been negatively associ-
ated with size at birth in a few small studies 
(Llanos and Ronco 2009; Ronco et al. 2005). 
Maternal urinary Cd is associated with both 
placenta and cord blood Cd (Kippler et al. 
2010a) and would be a useful exposure meas-
ure for evaluating combined effects of direct 
fetal Cd exposure and indirect effects due to 
placental accumulation of Cd. Maternal uri-
nary Cd concentrations were measured on only 
one occasion in early pregnancy, but urinary 
Cd concentrations have previously been shown 
to be rather constant throughout pregnancy 
(Hernandez et al. 1996).
There are several possible mechanisms by 
which maternal Cd exposure directly or indi-
rectly may affect size at birth. We have previ-
ously shown that pregnant women in Matlab 
had elevated Cd concentrations in their pla-
centas and that these Cd concentrations were 
inversely association with Zn in cord blood, 
suggesting that Cd may disturb Zn transfer to 
the fetus (Kippler et al. 2010a). Before that, 
an interaction between Cd and Zn in the pla-
centa, leading to decreased Zn transfer to the 
fetus, had been shown only in vitro and in 
women with increased Cd exposure via smok-
ing (Kuhnert et al. 1987; Wier et al. 1990). 
Because insufficient Zn transfer to the fetus 
is likely to have consequences for pregnancy 
outcomes, especially in terms of intrauter-
ine growth retardation and pre  term deliv-
ery (Jameson 1993), this has been suggested 
Figure 1. β-Coefficients and 95% CIs for maternal urinary Cd in each quantile [25th (Q25), 50th (Q50), and 
75th (Q75)] of birth weight, length, and head and chest circumference for boys (A) and girls (B). In boys, 
there were significant differences between the 25th and 50th quantile specific estimates (p = 0.046) for 
head circumference, and in girls, there was a significant difference between the 50th and 75th quantile 
specific estimates (p = 0.030) for chest circumference. No other significant differences between any of the 
specific quantile estimates were detected (p > 0.05). 
*Birth weight has been divided by 100 to fit the scale of the figure.
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Table 3. Multivariablea linear regression analyses of the association between maternal urinary Cd in gestational week 8 and size at birth.
All Boys (n = 712) Girls (n = 670)
Predicted B (95% CI) p-Value
Adjusted 
p-valueb B (95% CI) p-Value
Adjusted 
p-valueb B (95% CI) p-Value
Adjusted 
p-valueb
Interaction 
p-valuec
Birth weight (g)  –31.0 (–59, –2.8) 0.031 0.029 –17.0 (–59.4, 25.4) 0.43 0.46 –44.9 (–82.5, –7.3) 0.020 0.011 0.19
Birth length (cm)  –0.043 (–0.21, 0.12) 0.61 0.58 0.071 (–0.18, 0.32) 0.58 0.54 –0.14 (–0.36, 0.077) 0.20 0.14 0.11
Head circumference (cm)  –0.15 (–0.27, –0.026) 0.018 0.017 –0.051 (–0.23, 0.13) 0.58 0.58 –0.26 (–0.43, –0.088) 0.0031 0.0019 0.12
Chest circumference (cm)  –0.14 (–0.30, 0.021) 0.088 0.083 –0.071 (–0.32, 0.18) 0.58 0.59 –0.24 (–0.44, –0.030) 0.025 0.019 0.25
aAdjusted for maternal age, BMI, SES, hemoglobin at gestational week 14, urinary As at gestational week 8, and betel use (never/ever) and infant season of birth (premonsoon, mon-
soon, and postmonsoon) and gestational age (< 37 weeks = 1; ≥ 37 weeks = 0). Estimates for boys and girls combined were also adjusted for sex. bp-Value after seemingly unrelated 
estimation, to adjust for conducting multiple tests on correlated outcomes. cp-Value for the interaction term between maternal urinary Cd and sex (described in text).Kippler et al.
288  v o l u m e  120 | n u m b e r 2 | February 2012  •  Environmental Health Perspectives
as one of the main mechanisms for the 
Cd-related reduction in birth weight (Kippler 
et al. 2010a; Kuhnert et al. 1987; Ronco et al. 
2005). However, because we found a sex dif-
ference in the association between maternal 
urinary Cd and size at birth, that mechanism 
may only partly explain the present findings. 
Another possible explanation for our find-
ings may be the recently identified endocrine-
disrupting properties of Cd.
Glucocorticoid exposure in utero has 
been associated with impaired fetal growth 
(McTernan et al. 2001). A key regulator in 
the fetoplacental barrier toward maternal 
glucocorticoids is 11β-hydroxysteroid dehy-
drogenase type 2 (11β-HSD2), which inac-
tivates maternal cortisol to cortisone (Seckl 
and Holmes 2007). In fact, it has been shown 
that placental 11β-HSD2 gene expression 
is reduced in pregnancies with intrauterine 
growth restriction, and small-for-gestational-
age babies appear to have elevated cortisol con-
centrations (McTernan et al. 2001). However, 
the underlying mechanism is unknown. Cd 
seems to be one factor affecting 11β-HSD2; 
1 μM CdCl2 (cadmium chloride) markedly 
reduced 11β-HSD2 gene activity, mRNA, and 
protein levels in cultured human trophoblastic 
cells in vitro (Yang et al. 2006). On the other 
hand, very high Cd exposure of pregnant rats 
(50 mg/L in drinking water) did not alter pla-
cental 11β-HSD2, but corticosterone concen-
trations (corresponding to cortisol in humans) 
increased and the pup weights decreased 
(Ronco et al. 2009). Notably, the effect of pre-
natal glucocorticoid exposure appears to be sex 
specific. In mothers receiving glucocorticoid 
treatment for asthma, 11β-HSD2 activity was 
significantly decreased in placentas of female 
but not male fetuses, and this was associated 
with increased umbilical cord blood cortisol 
levels and reduced birth weight (Murphy et al. 
2003). Thus, decreased 11β-HSD2 activity 
and increased concentrations of cortisol may 
be fundamental features in female fetal growth 
impairment (Clifton and Murphy 2004).
Cd may also interfere with the insulin-
like growth factor (IGF) axis and thereby 
reduce fetal growth in a sex-specific man-
ner. Rats given drinking water with 50 mg 
Cd/L had lower concentrations of IGF-1 and 
insulin-like growth factor-binding protein 3 
(IGFBP-3) than did controls (Turgut et al. 
2005). In human pregnancies, both IGF-1 
and IGFBP-3 are usually positively associ-
ated with birth weight (Murphy et al. 2006). 
Furthermore, two epidemiologic studies 
have found that IGF-1 and IGFBP-3 levels 
in umbilical cord blood/plasma were higher 
in female than in male infants (Geary et al. 
2003; Vatten et al. 2002).
We also hypothesize that Cd may affect 
the sex-specific programming, which begins 
very early in pregnancy and may contribute 
to the vulnerability of the developing fetus to 
maternal stressors (Mueller and Bale 2008). 
In an experimental study on chick embryos, 
Cd was found to down-regulate gene expres-
sion (levels) of DNA methyltransferases regu-
lating the de novo DNA methylation, which is 
essential for normal embryogenesis (Doi et al. 
2011). Interestingly, female embryonic stem 
cells were found to lose DNA methylation 
at a much faster rate than did male stem cells 
(Ooi et al. 2010).
Low birth weight is a significant public 
health problem worldwide, and it has been 
associated with neonatal mortality and morbid-
ity, as well as increased risk for the development 
of diseases later in life (Murphy et al. 2006). 
The association between Cd and reduced birth 
weight in girls (an estimated decrease of 45 g 
for a 1-μg/L increase in maternal urinary Cd) 
corresponds to about one-quarter of the esti-
mated effect of smoking during pregnancy 
on birth weight (~ 200 g lower birth weight 
for mothers who smoke than for non  smoking 
mothers) (Rogers 2009), part of which may be 
mediated via the Cd inhaled with the tobacco 
smoke. To further put the effect size into per-
spective, an increase in birth weight of 37 g 
was achieved by supplementation with folic 
acid and iron in a double-blind randomized 
community trial in rural Nepal (Christian 
et al. 2003). In the present study, associations 
between Cd and birth size outcomes in girls 
were independent of SES and similar in small 
and larger infants; however, the relevance of 
our findings for birth outcomes in better-
  nourished populations needs to be evaluated.
We believe that the main source of Cd in 
this population is the diet, especially plant-
derived foods, because none of the women 
smoked. The median maternal urinary Cd 
concentration (median, 0.63 μg/L) was higher 
than that reported in young women in the 
United States (geometric mean, 0.27 μg/g 
creatinine) and Europe (median, 0.31 μg/L) 
(Åkesson et al. 2002; McElroy et al. 2007), 
probably due to the rice-based diet, because 
rice is known to take up Cd from the soil to 
a greater extent than many other plants. Rice 
samples collected from 63 families in the study 
area contained on average 69 μg Cd/kg dry 
weight (10th and 90th percentiles, 11–98 μg 
Cd/kg) (Kippler et al. 2010b), which would 
correspond to a daily intake of 25–35 μg Cd, 
assuming a daily consumption of 400–500 g 
rice grains for an adult person (Khan et al. 
2009). This daily Cd intake is similar to that 
in other Asian countries where rice is the main 
staple food and also to that in most individuals 
consuming vegetarian diets (European Food 
Safety Authority 2009; Ikeda et al. 2010). It is 
essential to investigate other potential sources 
of Cd, particularly vegetables and wheat, as 
well as agricultural fertilizers that may be a 
major contributor to Cd in agricultural soil.
Conclusions
We found significant inverse associations 
between maternal Cd exposure and birth 
anthropometry in girls, especially head cir-
cumference and birth weight, but no asso-
ciations in boys. These findings, along with 
evidence from previous experimental and 
observational studies, suggest that there may 
be sex differences in both toxicokinetics (i.e., 
intestinal uptake) and toxicodynamics of Cd. 
It is essential to follow the children through 
childhood to clarify whether the apparent 
effect on growth remains and whether the 
early-life Cd exposure is associated with other 
health outcomes later in childhood. This study 
clearly emphasizes the need to consider early-
life effects of Cd in health risk assessments 
and to reduce Cd pollution worldwide.
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